Most lately, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar regions as classical opioid receptors, it binds to some wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions being a scavenger https://heraclitusd319xyc0.blogs100.com/profile